Euripedes Constantino Miguel
From Wikipedia, the free encyclopedia
.jpg)
Euripedes Constantino Miguel Filho (born June 14, 1959) is a Brazilian psychiatrist and professor who is head of the Department of Psychiatry at FMUSP and associate adjunct professor at the Yale University School of Medicine. Between 2009 and 2019, he was an associate professor in the Department of Psychiatry at Duke University and, from 2009 to 2014, a research consultant at Massachusetts General Hospital, Harvard Medical School.
As a researcher, he has published over 500 articles. These works have been cited more than 24,000 times, resulting in an h-index of 84.[1][2] He has edited 24 books. He is a researcher at the São Paulo Research Foundation and a level 1A research productivity fellow at the National Council for Scientific and Technological Development. He coordinates the National Institute of Developmental Psychiatry and the National Center for Research and Innovation in Mental Health.
After completing his pre-university education at Colégio São Luís, Miguel entered the School of Medicine at the University of São Paulo, in 1977. In 1979, he was president of the Associação Atlética Acadêmica Oswaldo Cruz.[citation needed]
After completing his undergraduate degree, he entered the Medical Residency in General Psychiatry at the Psychiatry Institute of the Hospital das Clínicas, FMUSP. With his thesis concerning psychopathological changes in patients diagnosed with systemic lupus erythematosus, Dr. Miguel earned his doctorate under the supervision of Valentim Gentil Filho in 1992.[citation needed]
Miguel completed a post-doctoral fellowship at Massachusetts General Hospital, Harvard Medical School, with Michael Jenike as his principal supervisor.[citation needed]
Career
In 1994, he was one of the founders of the Projeto de Transtornos do Espectro Obsessivo-Compulsivo - PROTOC (Obsessive-Compulsive Spectrum Disorders Program). With the members of this group, he coordinated three thematic projects funded by the São Paulo Research Foundation (Fapesp) and was the principal investigator of a project funded by the National Institutes of Health (NIH) focused on research into the neurobiological signature of OCD. Since 2023, he has been the principal investigator of a project at the National Institute of Mental Health (NIMH) focused on the genetic signature of OCD in a diverse sample of 5,000 patients in Latin America. Since 2004, he has coordinated the Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders (C-TOC).
Since 1992, Miguel has been researching various topics related to Obsessive-Compulsive Disorder (OCD), including comorbidities, enhancement of medications used in treatment, clinical characterization, biological markers, and neural circuit. Recently,[when?] he has become responsible for the Child and Adolescent Psychiatry course in the Department of Psychiatry at the School of Medicine, USP, with the goal of advancing this field in the country.[citation needed]
Miguel coordinates the National Institute of Developmental Psychiatry. Established in 2008, the INPD was created with the goal of shifting the paradigm in psychiatric research from a focus on treating individuals who are already ill to a more proactive approach.
Miguel coordinates the National Center for Research and Innovation in Mental Health) launched in 2023 to preserve and continue the legacy of INPD and with the purpose of advancing and disseminating knowledge about mental health.
In 2009, Miguel took on the roles of Full Professor and Head of the Department of Psychiatry at the School of Medicine, University of São Paulo. In 2024, he was elected for the fifth time to hold this leadership position until 2026.[citation needed]
Awards
In 2012, Miguel received the 54th Jabuti Prize for the book “Clínica Psiquiátrica - A Visão do Departamento e do Instituto de Psiquiatria do HCFMUSP".
In 2018, the "Primeiros Laços" (First-ties) project, one of the early childhood intervention studies from INPD/CISM, won the Abril/DASA Social Medicine Award.
